has raised money to begin a human trial of its hair cloning technology.
According to the company’s website, the company has obtained “an
exclusive, worldwide license from the University of Pennsylvania to
develop and commercialise a breakthrough technology that has been
demonstrated to stimulate the genesis and development of new follicles.” It is announced it had completed a $5.5 million Series A financing round.